Tailored antiplatelet therapy for secondary prevention of ischemic stroke: myth or a desirable approach?
Bertelli
M
M
Luongo
R
R
Barcella
L
L
Cavalli
P
P
D002545:Brain Ischemia / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D018579:Patient Selection; D010597:Pharmacogenetics; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D018570:Risk Assessment; D055502:Secondary Prevention; D020521:Stroke / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D016896:Treatment Outcome
D010975:Platelet Aggregation Inhibitors